Rodrigues Michelle, McCormack Christopher, Yap Lee-Mei, Prince H Miles, Roberts Hugh, Williams Richard, Foley Peter
Dermatology Service, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Australas J Dermatol. 2009 May;50(2):129-32. doi: 10.1111/j.1440-0960.2008.00505.x.
A 40-year-old woman presented with a prolonged history of recurrent crops of erythematous papules and nodules on her abdomen, arms and legs. Histological examination of a cutaneous biopsy revealed Type A lymphomatoid papulosis. Over a 3-year period, some of the patient's lesions had proven to be resistant to treatment with topical and intralesional corticosteroids and systemic agents including methotrexate, tetracycline and nicotinamide. These resistant lesions were treated with two sessions of methyl aminolevulinate photodynamic therapy given 1 week apart. Review 11 months post-photodynamic therapy demonstrated complete clinical clearance at the treatment site. While photodynamic therapy is considered a standard non-surgical treatment option for non-melanoma skin cancers and has been described in a number of non-oncological indications, this is the first report of its use in lymphomatoid papulosis.
一名40岁女性,腹部、手臂和腿部反复出现红斑丘疹和结节,病史较长。皮肤活检的组织学检查显示为A型淋巴瘤样丘疹病。在3年的时间里,该患者的一些病变已证实对局部和病灶内使用皮质类固醇以及包括甲氨蝶呤、四环素和烟酰胺在内的全身药物治疗有抗性。这些抗性病变接受了相隔1周的两个疗程的甲基氨基乙酰丙酸光动力疗法治疗。光动力治疗11个月后的复查显示治疗部位临床完全清除。虽然光动力疗法被认为是非黑色素瘤皮肤癌的标准非手术治疗选择,并且已在许多非肿瘤学适应症中有所描述,但这是其用于淋巴瘤样丘疹病的首次报告。